Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Agarwal, Vishnu
- Design and Fabrication of Microbial Fuel Cell for Generation of Electricity
Abstract Views :535 |
PDF Views:113
Authors
Vishnu Agarwal
1,
Preetam Verma
2,
Anil Kumar Mathur
1,
Ankur Singh
3,
Dhirendra Kumar
3,
Varun Kumar Yadav
3
Affiliations
1 Faculty of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad 211004, IN
2 Jacob School of Biotechnology, Sam Higginbottom Institute of Agriculture, Technology & Sciences (Deemed to be University) Allahabad, 211007, IN
3 Dept. of Applied Mechanics (Biotechnology) Motilal Nehru National Institute of Technology, Allahabad 211004, IN
1 Faculty of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad 211004, IN
2 Jacob School of Biotechnology, Sam Higginbottom Institute of Agriculture, Technology & Sciences (Deemed to be University) Allahabad, 211007, IN
3 Dept. of Applied Mechanics (Biotechnology) Motilal Nehru National Institute of Technology, Allahabad 211004, IN
Source
Indian Journal of Science and Technology, Vol 4, No 3 (2011), Pagination: 167-169Abstract
Energy need has been increasing worldwide exponentially. At present global energy requirements are mostly dependent on the fossil fuels, which eventually lead to foreseeable depletion of limited fossil energy sources. More recently, generation of electricity using microbial fuel cells (MFC) is seemingly gaining importance in the research. MFC is a biochemical-catalyzed system which generates electrical energy through the oxidation of biodegradable organic matter in the presence of either fermentative bacteria or enzyme under mild reaction conditions (ambient temperature and pressure) and bacterial energy is directly converted to electrical energy and to close the cycle, protons migrate through a proton exchange membrane (PEM) from anode to cathode. The present work deals with the designing and fabrication of two-chambered salt bridge microbial fuel cell with specific dimension. The efficiency of fabricated MFCs was checked by variation in current produced on different days of operation of MFC and effect of using dextrose in anodic chamber of MFC. The MFC was operated for 7 days with or without dextrose as carbon source. It was observed that while running MFC without dextrose the maximum current obtained was 13.6 μA and maximum voltage obtained was 146.8 mV. However while using 5% dextrose solution in the anodic-chamber the maximum current and voltage obtained was 170 μA and 216 mV respectively.Keywords
Anode, Salt Bridge, Dextrose, CurrentReferences
- Aelterman P, Rabaey K, Clauwaert P and Verstraete W(2006) Microbial fuel cells for wastewater treatment. Water Sci. Technol. 54, 9-15.
- Biffinger JC, Byrd JN, Dudley BL and Ringeisen BR (2008) Oxygen exposure promotes fuel diversity for Shewanella oneidensis microbial fuel cells. Biosens. Bioelectron. 23, 820–826.
- Clauwaert P, Rabaey K, Aelterman P, de Schamphelaire L, Pham T H, Boeckx P, Boon N and Verstraete W(2007). Biological denitrification in microbial fuel cells. Environ. Sci. Technol. 41, 3354–3360.
- Heilmann J and Logan BE (2006) Production of electricity from proteins using a microbial fuel cell. Water Environ. Res. 78, 531–537.
- Luo Y, Liu G, Zhang R and Zhang C (2010). Power generation from furfural using the microbial fuel cell. J. Power Sources. 195, 190–194.
- Mohan Y, Muthu KSM and Das D (2008). Electricity generation using microbial fuel cells. Int. J. Hydrogen Energy. 33, 423–426.
- Rodrigo MA, Cañizares P, García H, Linares JJ and Lobato J (2009) Study of the acclimation stage and of the effect of the biodegradability on the performance of a microbial fuel cell. Biores. Technol. 100, 4704–4710.
- Nanoparticle Based Drug Delivery System: Advantages and Applications
Abstract Views :664 |
PDF Views:130
Authors
Affiliations
1 Dept. of Applied Mechanics (Biotechnology), Motilal Nehru National Institute of Technology, Allahabad, 211004, IN
1 Dept. of Applied Mechanics (Biotechnology), Motilal Nehru National Institute of Technology, Allahabad, 211004, IN
Source
Indian Journal of Science and Technology, Vol 4, No 3 (2011), Pagination: 177-180Abstract
There has been a considerable research interest in the area of drug delivery systems using nanoparticles. Nanostructured biomaterials have unique physicochemical properties such as ultra small and controllable size, large surface area to mass ratio, high reactivity and functionalizable structure. It alter and improve the pharmacokinetic and pharmacodynamic properties of various types of drug molecules that are capable of targeted delivery of both imaging agents and anticancer drugs and early detection of cancer lesions, determination of molecular signatures of the tumor by noninvasive imaging and, most importantly, molecular targeted cancer therapy. These properties can be applied on drug to overcoming some of the limitations in traditional therapeutics. They have been used in vivo to protect the drug entity in the systemic circulation, restrict access of the drug to the chosen sites and to deliver the drug at a controlled and sustained rate to the site of action, minimizes undesirable side effects of the drugs and allow for more efficient use of the drug. It should be present at appropriate concentrations at the target site, and it should not lose its activity or therapeutic efficacy while in circulation. Here, we review various aspects of nanoparticle formulation, characterization, effect of their characteristics and their applications in delivery of drug molecules, improving the targated delivery of therapeutic agents, the potential of nanomedicine, development of novel and more effective diagnostic and screening techniques to extend the limits of molecular diagnostics and challenges in synthesizing nanoparticle platforms for delivering various drugs.Keywords
Drug Delivery, Microbes, Liposomes, Polymeric Nanoparticles, Ceramic Nanoparticles, DendrimersReferences
- Ahmad Z, Pandey R, Sharma S and Khuller GK (2006) Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potential. Ind. J. Chest Dis. Allied. Sci. 48, 171-176.
- Balogh L, Swanson DR, Tomalia DA, Hagnauer GL and McManus AT (2001) Dendrimer-silver complexes and nanocomposites as antimicrobial agents. Nano.Lett. 1, 18-21
- Bawa R, Bawa SR and Meibius SB et al. (2005) Protecting new ideas and invention in nanomedicine via patent. Nanomedicine. 1(2), 150-158.
- Davis ME, Chen ZG and Shin DM (2008) Nanoparticle therapeutics: an emerging treatment modality for cancer. Nature. 7, 771-782.
- Devarakonda B, Hill RA, Liebenberg W, Brits M and de Villiers MM (2005) Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins. Int. J. pharm. 304(1-2), 193-209.
- Hughes GA (2005) Nanostructure-mediated drug delivery. Nanomedicine. 1, 22– 30.
- Jain N, Jain R, Thakur N, Gupta BP, Jain DK, Banveeri J and Jain S (2010) Nanotechnology: a safe and effective drug delivery system. Asian J. Pharm. Clin. Res. 3, Issue 3.
- Omri A, Suntres ZE and Shek PN (2002) Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection. Biochem. Pharmacol. 64, 1407-1413.
- Pandey R and Khuller GK (2006) Oral nanoparticlebased antituberculosis drug delivery to the brain in an experimental model. J. Antimicrob. Chemotherapy. 57(6), 1146-1152.
- Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R and Langer R (2007) Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751-760.
- Pragati S, Ashok S and Kuldeep S (2009) Recent advances in periodontal drug delivery systems. Int. J. D. Del. 1, 1-14.
- Rao DP, Srivastav SK, Prasad C, Saxena R and Asthana S (2010) Role of nanoparticles in drug delivery. Int. J. Nanotech. App. 0973-631X Volume 4.
- Schumacher I and Margalit R (1997) Liposomeencapsulated ampicillin: physicochemical and antibacterial properties. J. Pham. Sci. 86, 635-641.
- Wadher K, Kalsait R and Umekar M (2009) Alternate drug delivery system: recent advancement and future challenges. Arch. Pharm. Sci. Res. 1 No. 2, 97 - 105.
- Yih TC and Al-Fandi M (2006) Engineered nanoparticles as precise drug delivery systems. J. Cell. Biochem. 97, 1184–1190.
- Zhang L, Gu FX, Chan JM, Wang AZ, Langer R.S and Farokhzad OC (2008) Nanoparticles in medicine: therapeutic applications and developments. Clin. Pharmacol. Ther. 83(5), 761-769.
- Zhang L, Pornpattananangkul D, Hu CMJ and Huang CM (2010) Development of nanoparticles for antimicrobial drug delivery. Curr. Med. Chem.17, 585-594.